Renshuai Zhang

2.5k total citations
84 papers, 1.9k citations indexed

About

Renshuai Zhang is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Renshuai Zhang has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 16 papers in Organic Chemistry and 13 papers in Cancer Research. Recurrent topics in Renshuai Zhang's work include Advanced biosensing and bioanalysis techniques (11 papers), Nanoplatforms for cancer theranostics (8 papers) and Cholesterol and Lipid Metabolism (8 papers). Renshuai Zhang is often cited by papers focused on Advanced biosensing and bioanalysis techniques (11 papers), Nanoplatforms for cancer theranostics (8 papers) and Cholesterol and Lipid Metabolism (8 papers). Renshuai Zhang collaborates with scholars based in China, Singapore and Australia. Renshuai Zhang's co-authors include Dongming Xing, Wujun Chen, Hongfei Jiang, Pengwei Chen, Fan‐Dong Kong, Xiaofei Qin, Guojun Pan, Yudong Wu, Jie Wang and Dongming Xing and has published in prestigious journals such as Chemical Communications, Journal of Agricultural and Food Chemistry and Coordination Chemistry Reviews.

In The Last Decade

Renshuai Zhang

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renshuai Zhang China 23 1.0k 313 283 249 219 84 1.9k
Jinha Yu South Korea 22 764 0.8× 258 0.8× 293 1.0× 429 1.7× 264 1.2× 61 1.9k
Rosa Maria Iacobazzi Italy 25 696 0.7× 399 1.3× 255 0.9× 158 0.6× 339 1.5× 77 1.8k
David Y. Léger France 25 748 0.7× 316 1.0× 170 0.6× 212 0.9× 249 1.1× 57 1.8k
Antonio Pezone Italy 15 1.2k 1.2× 368 1.2× 204 0.7× 236 0.9× 136 0.6× 30 2.3k
Bertrand Liagre France 31 1.6k 1.6× 372 1.2× 315 1.1× 255 1.0× 503 2.3× 107 3.1k
Hibah M. Aldawsari Saudi Arabia 28 864 0.9× 304 1.0× 145 0.5× 146 0.6× 404 1.8× 84 2.4k
Abolfazl Barzegar Iran 23 877 0.9× 253 0.8× 233 0.8× 210 0.8× 228 1.0× 83 1.9k
Tongsheng Chen China 31 1.2k 1.2× 628 2.0× 160 0.6× 410 1.6× 190 0.9× 142 2.6k
Shuai Lü China 31 1.2k 1.2× 171 0.5× 414 1.5× 426 1.7× 219 1.0× 144 2.9k
Xingmei Duan China 26 847 0.8× 280 0.9× 176 0.6× 110 0.4× 341 1.6× 56 1.7k

Countries citing papers authored by Renshuai Zhang

Since Specialization
Citations

This map shows the geographic impact of Renshuai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renshuai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renshuai Zhang more than expected).

Fields of papers citing papers by Renshuai Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renshuai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renshuai Zhang. The network helps show where Renshuai Zhang may publish in the future.

Co-authorship network of co-authors of Renshuai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Renshuai Zhang. A scholar is included among the top collaborators of Renshuai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renshuai Zhang. Renshuai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Renshuai, et al.. (2025). Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies. Pharmacology & Therapeutics. 276. 108934–108934.
2.
Zhang, Renshuai, Songbo Xie, Jie Ran, & Te Li. (2024). Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety. Journal of Cellular Physiology. 239(5). e31255–e31255. 8 indexed citations
3.
Chen, Pengwei, Hao Li, Quancai Li, et al.. (2024). Identification of targets and comparative study of administration methods for the lipid-lowering effects of fucoidan from Saccharina japonica. International Journal of Biological Macromolecules. 290. 139102–139102. 1 indexed citations
4.
Ma, Changxi, et al.. (2024). Research on Parking Space Detection and Prediction Model Based on CNN-LSTM. IEEE Access. 12. 30085–30100. 6 indexed citations
5.
Zhou, Ping, Lin Li, Renshuai Zhang, et al.. (2024). Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis. Theranostics. 14(13). 4983–5000. 15 indexed citations
6.
Wang, Jie, Jie Wang, Ping Li, et al.. (2024). Ultrathin Flexible Silica Nanosheets with Surface Chemistry‐Modulated Affinity to Mammalian Cells. Small. 20(40). e2401772–e2401772. 2 indexed citations
7.
Zhang, Renshuai, et al.. (2023). Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review. International Journal of Biological Macromolecules. 249. 125993–125993. 37 indexed citations
8.
Zhang, Renshuai, Hao Li, Pengwei Chen, Gang Zhang, & Ning Liu. (2023). Multifunctional small-molecule theranostic agents for tumor-specific imaging and targeted chemotherapy. Bioorganic Chemistry. 137. 106576–106576. 13 indexed citations
9.
Jiang, Hongfei, Qiuyu Gong, Renshuai Zhang, & Hongye Yuan. (2023). Tetrazine-based metal-organic frameworks. Coordination Chemistry Reviews. 499. 215501–215501. 19 indexed citations
10.
Zhang, Min, Renshuai Zhang, Yunxia Dong, et al.. (2023). Oxygen supplementation liposomes for rheumatoid arthritis treatment via synergistic phototherapy and repolarization of M1-to-M2 macrophages. Chemical Engineering Journal. 459. 141484–141484. 28 indexed citations
11.
Liu, Xinlin, Junwen Deng, Renshuai Zhang, et al.. (2023). The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy. Frontiers in Immunology. 14. 1335252–1335252. 12 indexed citations
12.
Jiang, Hongfei, Qiuyu Gong, & Renshuai Zhang. (2023). Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation. Frontiers in Immunology. 14. 1301539–1301539.
13.
Zhang, Renshuai, et al.. (2022). Tetrazine bioorthogonal chemistry makes nanotechnology a powerful toolbox for biological applications. Nanoscale. 15(2). 461–469. 14 indexed citations
14.
Zhao, Gaoxiang, et al.. (2022). Tetrazine bioorthogonal chemistry derived in vivo imaging. Frontiers in Molecular Biosciences. 9. 1055823–1055823. 19 indexed citations
15.
Jiang, Hongfei, et al.. (2021). Nanotechnologies for Reactive Oxygen Species“Turn-On” Detection. Frontiers in Bioengineering and Biotechnology. 9. 780032–780032. 17 indexed citations
16.
Luo, Jiao, Renshuai Zhang, Xuehe Wang, et al.. (2020). Binding properties of marine bromophenols with human protein tyrosine phosphatase 1B: Molecular docking, surface plasmon resonance and cellular insulin resistance study. International Journal of Biological Macromolecules. 163. 200–208. 11 indexed citations
17.
Gong, Qiuyu, Wenjing Qin, Peng Xiao, et al.. (2019). Internal standard fluorogenic probe based on vibration-induced emission for visualizing PTP1B in living cells. Chemical Communications. 56(1). 58–61. 11 indexed citations
18.
Zhao, Yue, Chuanlong Guo, Lijun Wang, et al.. (2017). A novel fluorinated thiosemicarbazone derivative- 2-(3,4-difluorobenzylidene) hydrazinecarbothioamide induces apoptosis in human A549 lung cancer cells via ROS-mediated mitochondria-dependent pathway. Biochemical and Biophysical Research Communications. 491(1). 65–71. 18 indexed citations
19.
Zhang, Renshuai, Shaopeng Chen, Xiaowei Zhang, et al.. (2016). Synthesis and evaluation of novel non-covalent binding quinazoline glycoside derivatives targeting the L858R and T790M variants of EGFR. RSC Advances. 6(43). 36857–36862. 7 indexed citations
20.
Zhang, Renshuai, Shaopeng Chen, Guanzhao Wu, Shengbiao Wan, & Tao Jiang. (2015). Design and Synthesis of Novel EGFR Inhibitors with L‐Rhamnose–Benzoxazinone Hybrids. Journal of Heterocyclic Chemistry. 53(5). 1563–1569. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinha Yu Breakdown of academic impact, for papers by Rosa Maria Iacobazzi Breakdown of academic impact, for papers by David Y. Léger Breakdown of academic impact, for papers by Antonio Pezone Breakdown of academic impact, for papers by Bertrand Liagre Breakdown of academic impact, for papers by Hibah M. Aldawsari Breakdown of academic impact, for papers by Abolfazl Barzegar Breakdown of academic impact, for papers by Tongsheng Chen Breakdown of academic impact, for papers by Shuai Lü Breakdown of academic impact, for papers by Xingmei Duan
Rankless by CCL
2026